NOW surged +8.63% during regular trading hours, rebounding sharply from Thursday's close of $89.52 to $97.25 as beaten-down software names staged a broad recovery. The rally was fueled by a sector-wide relief bounce after the 10-year Treasury yield dropped below 4.5%, easing valuation pressure on high-multiple growth stocks that had been deeply oversold.

HQ shares are trading down -6.75% during regular market hours on June 26, falling to $24.17 from a previous close of $25.92, extending a multi-day selloff. The decline marks the fifth consecutive losing session as the stock continues to unwind from its parabolic rally that peaked at $45 on June 22, a drop of over -46% from that high.

Tower Semiconductor shares fell -8.53% during regular market hours on Friday, extending a multi-day pullback from the stock's 52-week high of $319.94 reached earlier in the week. The primary catalyst is a broad semiconductor sector selloff, with the iShares Semiconductor ETF (SOXX) also trading sharply lower as investors rotate out of high-momentum chip names.

CAPR shares fell -12.34% during regular trading on Friday, closing at $26.65 after the company announced the FDA will hold an advisory committee meeting on July 29 to review its Biologics License Application for Deramiocel. The sell-off was triggered by investor anxiety over the AdComm review, which introduces additional regulatory uncertainty despite the company simultaneously reporting positive five-year efficacy and safety data for its DMD cell therapy.

FORM shares fell -8.68% to $135.84 in after-hours trading on Friday, extending a sharp regular-session decline from the prior close of $148.75. The selloff was driven by a broad global semiconductor rout after South Korea's Kospi Index plunged more than -5%, triggered by heavy selling in Samsung Electronics and SK Hynix.

Bloom Energy shares plunged -13.60% during regular trading on Friday, falling from a previous close of $309.18 to around $267, erasing a significant portion of this week's gains. The primary catalyst was a Jefferies analyst note flagging the stock's rich valuation following its meteoric +1,100% rise over the past year, sparking a sharp sell-off.

LLY shares surged +6.67% during regular market trading on June 26, climbing from a prior close of $1,127.69 to $1,202.86. The primary catalyst was the European Medicines Agency's CHMP issuing a positive opinion recommending approval of Jaypirca (pirtobrutinib) for chronic lymphocytic leukemia across all lines of therapy in the EU.

ON Semiconductor shares plunged -21.19% to $93.58 during Friday's regular session, extending a steep premarket selloff that began after Thursday's close. The primary catalyst was the announcement of a $7 billion all-stock acquisition of Synaptics (SYNA), with investors reacting negatively to significant shareholder dilution and the deal's strategic fit.

BE shares are declining approximately 9% in today's session, extending recent volatility as the stock pulls back from record highs reached earlier this week. The primary catalyst is a wave of competition concerns: a landmark U.S. Department of Energy announcement of $17.5 billion in financing to accelerate construction of 10 new large-scale nuclear reactors by 2030 is pressuring the bull case for Bloom's fuel cell monopoly in AI data centers.

OMER shares are plunging approximately 26% in premarket trading on Friday, June 26, 2026, from a prior close of $10.72 to around $7.93. The primary catalyst is a negative opinion issued by the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), which rejected the marketing authorization application for narsoplimab (YARTEMLEA) in the treatment of hematopoietic stem cell transplant-associated thrombotic microangiopathy (TA-TMA) in Europe.

WDC shares are declining approximately 7% in premarket trading on Friday, June 26, 2026, from a prior close of approximately $675 to around $628, reversing a portion of the stock's extraordinary year-to-date rally. The primary driver is a continuation of the global technology and semiconductor selloff, which has gripped memory and storage stocks across multiple sessions and accelerated Friday with Asian markets posting steep losses overnight.

ON shares are falling approximately 12% in premarket trading on Friday, June 26, 2026, from a prior close of $118.74 to around $104.36. The primary catalyst is onsemi's announcement of a definitive agreement to acquire Synaptics (SYNA) in an all-stock deal valued at approximately $7 billion — the company's largest acquisition in its history.

MU shares are declining approximately 6% in premarket trading on Friday, June 27, 2026, reversing a portion of the prior session's 14.5%+ earnings-driven rally. The primary catalyst is a broad, global technology and semiconductor selloff, with investors booking profits following the stock's massive post-earnings surge.

Entire 2026 high-bandwidth memory (HBM) supply is sold out under fixed-price contracts, providing revenue visibility amid surging artificial intelligence (AI) demand. Upcoming fiscal Q3 2026 earnings release expected to offer updated guidance on Q4 revenue, gross margins, and HBM4 ramp progress for NVIDIA’s Vera Rubin platform.

Net sales fell to $326.0 million from $359.7 million in the prior-year period. The company reported a net loss of $159.7 million, or $1.73 per diluted share, compared with net income of $36.7 million, or $0.36 per diluted share, last year.

BlackBerry reported fiscal Q1 2027 revenue of approximately $153 million, up 26% year-over-year. Adjusted EBITDA grew 144% year-over-year, reflecting improved operational efficiency.

Reported adjusted EPS of $1.73, beating consensus estimates of approximately $1.70–$1.71. Net sales rose 22.9% year-over-year to $2.48 billion, driven by strong demand and acquisitions.

Net sales reached $1.198 billion for the quarter ended May 31, 2026, marking a 1.6% increase year over year. Adjusted diluted earnings per share came in at $5.31, exceeding analyst estimates of approximately $5.12.

Net sales rose 16.7% year-over-year to reflect strong contribution from the McCormick de Mexico acquisition, with organic sales growth of 1.7%. Adjusted earnings per share reached $0.80, beating consensus estimates and rising 15.9% from $0.69 in the prior-year quarter.

Darden reported fiscal 2026 fourth-quarter total sales of $3.72 billion, up 13.7% year-over-year, including a 53rd week. Adjusted diluted earnings per share from continuing operations reached $3.66, exceeding analyst expectations.